Job Summary La Division « Heath and Biosciences » de IFF est un des leaders mondiaux dans le domaine des bio-ingrédients. Au sein du département de R&D, l’équipe « Strain Development » est impliquée dans le développement de connaissances sc...
Nous sommes à la recherche d'un(e) Technicien(ne) de Production basé(e) à Loos dans le Nord de la France. Nous Sommes un établissement de la société Polyplus SA (PME en Biotechnologie), filiale de Sartorius. Notre activité s'articule auto...
Offer Description Mission. - Design new experiments through simulations using the Monte Carlo application. Functions to be developed - Build neutron detection systems. - Perform experiments. - Participate in the acquisition of exper...
The BBC hears the owner of the luxury store scoped out his victims on the shop floor, assaulted them in London, Paris and St Tropez, and pressured them to keep quiet. Continue Reading »
Sebi initiated action into Axis Capital after publication of a report titled ‘Is Axis Capital an Investment Bank or a Hedge Fund?’ authored by a research analyst. Continue Reading »
Experts rule out a runaway rally, given the steep valuations across large swathes of the market, expecting large caps to outperform broader markets. Continue Reading »
As of 10 a.m. Eastern time, the Dow Jones was up 1.2 per cent, the Nasdaq Composite was 2.2 per cent higher, and the S&P 500 was 1.5 per cent higher Continue Reading »
While foreign investors remain wary due to high valuations, Wood believes India’s domestic fundamentals will help cushion its markets from global volatility. Continue Reading »
The Indian stock market has gained significantly this year, with the Sensex up 15% and Nifty 50 up 17%. Experts recommend quality stocks for long-term gains amid optimism and caution. Top picks include Persistent Systems and HDFC Life. Continue Reading »
Earlier this month, global brokerage firm Goldman Sachs downgraded Indus Towers from a 'Neutral' rating to 'Sell,' lowering the target price to ₹220. Continue Reading »
Centrum Broking has initiated coverage on the wealth management sector, issuing a REDUCE rating for 360 One WAM and Nuvama Wealth. Target prices are ₹1,050 and ₹7,180, respectively, reflecting downsides for both amid a growing market for wealth management in India. Continue Reading »